$ARCT Помните, что WFC поставил таргет в 118 🐝 $ARCT 🕒 чт, 7 янв. 2021 г., 14:24:00 MSK Arcturus Therapeutics initiated with an Overweight at Wells Fargo (https://thefly.com/permalinks/entry.php/id3222298/ARCT-Arcturus-Therapeutics-initiated-with-an-Overweight-at-Wells-Fargo) Wells Fargo analyst Jim Birchenough initiated coverage of Arcturus Therapeutics with an Overweight rating and $118 price target. Birchenough believes that Arcturus has validated the potential value and differentiation of its self-amplifying mRNA delivery through novel lipid nanoparticle suspension and is poised for success with its lead mRNA vaccine ARCT-021 and sees a window for ARCT-021 to achieve competitive data with a superior dose form and drive significant value.